Reactive oxygen species and dopamine receptor function in essential hypertension

Clinical and Experimental Hypertension

Volumn 31, Issue 2, 2009, Pages 156-178

  Zeng, Chunyu ^a   Villar, Van Anthony M ^b   Yu, Peiying ^b   Zhou, Lin ^a   Jose, Pedro A ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine receptor; Essential hypertension; Reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BICARBONATE CHLORIDE ANTIPORTER; CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 2; GLYCOPROTEIN GP 91; HEME OXYGENASE 1; HORMONE; HUMORAL ANTIBODY; MESSENGER RNA; PROTEIN P40; PROTEIN P47; PROTEIN P67; RAC1 PROTEIN; RAC2 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SODIUM PROTON EXCHANGE PROTEIN 3; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNINDEXED DRUG; SODIUM;

BLOOD PRESSURE REGULATION; DIURESIS; ESSENTIAL HYPERTENSION; HEART FAILURE; HEART INFARCTION; HUMAN; KIDNEY FAILURE; NATRIURESIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RECEPTOR GENE; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; RISK FACTOR; SODIUM TRANSPORT; STROKE; VASODILATATION; ANIMAL; EVIDENCE BASED MEDICINE; GENETIC TRANSDUCTION; GENETICS; GENOTYPE; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; CYCLIC AMP; EVIDENCE-BASED MEDICINE; GENOTYPE; HUMANS; HYPERTENSION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTORS, DOPAMINE; SODIUM; TRANSDUCTION, GENETIC;

EID: 66949162985     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960802621283     Document Type: Review

References (181)

1. Ruilope L, Kjeldsen SE, de la Sierra A, Mancia G, Ruggenenti P, Stergiou GS, Bakris GL, Giles TD. The kidney and cardiovascular risk - implications for management: A consensus statement from the European Society of Hypertension. Blood Press 2007; 16:72-79.
2. Erdine S, Aran SN. Current status of hypertension control around the world. Clin Exp Hypertens 2004; 26:731-738.
3. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
4. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005; 85:679-715.
5. Zeng C, Zhang M, Asico LD, Eisner GM, Jose PA. The dopaminergic system in hypertension. Clin Sci (London) 2007; 112:583-597.
6. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 2003; 228:134-142.
7. Carey RM. Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 2001; 38:297-302.
8. Amenta F, Ricci A, Rossodivita I, Avola R, Tayebati SK. The dopaminergic system in hypertension. Clin Exp Hypertens 2001; 23:15-24.
9. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006; 71: 247-258.
10. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 2005; 289:R913-R935.
11. Dikalov S, Griendling KK, Harrison DG. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 2007; 49:717-727.
12. White BH, Sidhu A. Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: A mechanism for defective dopamine D1A receptor/G-protein coupling. J Hypertens 1998; 16:1659-1665.
13. 1 receptor-G protein coupling and function in old Fischer 344 rats. Am J Physiol Renal Physiol 2006; 291:F945-F951.
14. 1 receptor function in streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 2004; 286:F451-F457.
15. Wilcox CS, Gutterman D. Focus on oxidative stress in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 2005; 288:H3-H6.
16. Schneider C, Porter NA, Brash AR. Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J Biol Chem 2008; 283:15539-15543.
17. Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR, Jr. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 2008; 299: 2287-2293.
18. Boyden PA, Davies SS, Viswanathan PC, Amarnath V, Balser JR, Roberts LJ. Potential role of isoketals formed via the isoprostane pathway of lipid peroxidation in ischemic arrhythmias. J Cardiovasc Pharmacol 2007; 50:480-486.
19. Vincent HK, Innes KE, Vincent KR. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007; 9:813-839.
20. Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 2006; 55:928-934.
21. Tanaka M, Umemoto S, Kawahara S, Kubo M, Itoh S, Umeji K, Matsuzaki M. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens Res 2005; 28:67-77.
22. Abraham NG, Asija A, Drummond G, Peterson S. Heme oxygenase -1 gene therapy: Recent advances and therapeutic applications. Curr Gene Ther 2007; 7:89-108.
23. Maines MD. The heme oxygenase system: Update 2005. Antioxid Redox Signal 2005; 7:1761-1766
24. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002; 40:511-515.
25. Sato A, Sakuma I, Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol 2003; 285:H2345-H2354.
26. 2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 2003; 93:573-580.
27. 2 leads to hypertension. Hypertension 2003; 42:25-30.
28. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 2007; 87:245-313.
29. Gill PS, Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal 2006; 8:1597-1607.
30. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8:691-728.
31. 2 receptor-deficient mice. Hypertension 2007; 49:672-678.
32. Nozoe M, Hirooka Y, Koga Y, Sagara Y, Kishi T, Engelhardt JF, Sunagawa K. Inhibition of Rac1-derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats. Hypertension 2007; 50:62-68.
33. Li H, Witte K, August M, Brausch I, Godtel-Armbrust U, Habermeier A, Closs EI, Oelze M, Munzel T, Forstermann U. Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol 2006; 47:2536-2544.
34. Watanabe T, Yasunari K, Nakamura M, Maeda K. Carotid artery intima-media thickness and reactive oxygen species formation by monocytes in hypertensive patients. J Hum Hypertens 2006; 20:336-340.
35. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003; 41:341-346.
36. Silva GB, Ortiz PA, Hong NJ, Garvin JL. Superoxide stimulates NaCl absorption in the thick ascending limb via activation of protein kinase C. Hypertension 2006; 48:467-472.
37. Han HJ, Park SH, Park KM, Yoon BC, Kim TS, Lee JH. Effect of caffeic acid on apical transporters' dysfunction of renal proximal tubule cells under oxidative stress in vitro. Planta Med 2002; 68:483-486.
38. Nowak G, Bakajsova D, Clifton GL. Protein kinase C-epsilon modulates mitochondrial function and active Na+ transport after oxidant injury in renal cells. Am J Physiol Renal Physiol. 2004; 286:F307-F316.
39. - exchanger by angiotensin II and angiotensin II type 1 receptor distribution in membrane microdomains. Hypertension 2008; 51:1332-1338.
40. 1 receptor dysfunction and hypertension via mechanisms that involve nuclear factor-kappaB and protein kinase C. J Am Soc Nephrol 2007; 18:1446-1457.
41. Garvin JL, Ortiz PA. The role of reactive oxygen species in the regulation of tubular function. Acta Physiol Scand 2003; 179:225-232.
42. Kojsova S, Jendekova L, Zicha J, Kunes J, Andriantsitohaina R, Pechanova O. The effect of different antioxidants on nitric oxide production in hypertensive rats. Physiol Res 2006; 55:S3-S16.
43. Schupp N, Schmid U, Rutkowski P, Lakner U, Kanase N, Heidland A, Stopper H. Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging. Am J Physiol Renal Physiol 2007; 292:F1427-F1434.
44. Vera T, Kelsen S, Yanes LL, Reckelhoff JF, Stec DE. HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. Am J Physiol Regul Integr Comp Physiol 2007; 292:R1472-R1478.
45. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004; 44:248-252.
46. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002; 346:1954-1962.
47. Lip GY, Edmunds E, Nuttall SL, Landray MJ, Blann AD, Beevers DG. Oxidative stress in malignant and non-malignant phase hypertension. J Hum Hypertens 2002; 16:333-336.
48. Lee VM, Quinn PA, Jennings SC, Ng LL. NADPH oxidase activity in preeclampsia with immortalized lymphoblasts used as models. Hypertension 2003; 41:925-931.
49. Ward NC, Hodgson JM, Puddey IB, Mori TA, Beilin LJ, Croft KD. Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle. Free Radic Biol Med 2004; 36:226-232.
50. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Saez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003; 41:1096-1101.
51. Minuz P, Patrignani P, Gaino S, Seta F, Capone ML, Tacconelli S, Degan M, Faccini G, Fornasiero A, Talamini G, Tommasoli R, Arosio E, Santonastaso CL, Lechi A, Patrono C. Determinants of platelet activation in human essential hypertension. Hypertension 2004; 43:64-70.
52. Cracowski JL, Baguet JP, Ormezzano O, Bessard J, Stanke-Labesque F, Bessard G, Mallion JM. Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension 2003; 41:286-288.
53. Cosentino F, Patton S, d'Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T, Luscher TF. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998; 101:1530-1537.
54. 3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2008; 294(6):H2761-H2768.
55. O'Connell DP, Aherne AM, Lane E, Felder RA, Carey RM. Detection of dopamine receptor D1A subtype-specific mRNA in rat kidney by in situ amplification. Am J Physiol 1998; 274:F232-F241.
56. Yamaguchi I, Yao L, Sanada H, Ozono R, Mouradian MM, Jose PA, Carey RM, Felder RA. Dopamine D1A receptors and renin release in rat juxtaglomerular cells. Hypertension 1997; 29:962-968
57. 2 receptor mRNAs in the rat systemic and pulmonary vasculatures. Mol Cells 1999; 9:417-421.
58. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19:233-246.
59. 1A receptor induces antinatriuresis in conscious rats. Hypertension 1999; 33:504-510.
60. Sanada H, Xu J, Watanabe H, Jose PA, Felder RA. Differential expression and regulation of dopamine-1 (D-1) and dopamine-5 (D-5) receptor function in human kidney. Am J Hypertens 2000; 13:156A (abstract).
61. Albrecht FE, Drago J, Felder RA, Printz MP, Eisner GM, Robillard JE, Sibley DR, Westphal HJ, Jose PA. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 1996; 97:2283-2288.
62. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 1993; 21:767-771.
63. - exchanger in immortalized SHR proximal tubular epithelial cells. Am J Physiol Renal Physiol 2004; 286:F1120-F1126.
64. + exchanger interactions in the kidney in hypertension. Hypertension 2000; 36:395-399.
65. 1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action. Eur J Pharmacol 2003; 473:185-190.
66. Yamauchi M, Kobayashi Y, Shimoura K, Hattori K, Nakase A. Endothelium-dependent and -independent relaxation by dopamine in the rabbit pulmonary artery. Clin Exp Pharmacol Physiol. 1992; 19:401-410.
67. 1 dopamine receptor transregulation in hypertension. Hypertension 2004; 43:654-660.
68. 3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension 2004; 43:673-679.
69. Ca channel activity in coronary artery smooth muscle cells. Circ Res 2000; 86:897-905.
70. Natarajan AR, Han G, White R, Jose PA. The human D5 dopamine receptor mediates big KCa channel activity in human coronary artery smooth muscle cells. Hypertension 2006; 48:e80.
71. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 1990; 15:560-569.
72. Chen CJ, Lokhandwala MF. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens A 1992; 14:615-628.
73. - cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int 2000; 57:534-543.
74. 1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int 2006; 70:1072-1079.
75. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, Felder RA. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 1999; 33:1036-1042.
76. Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989; 84:1849-1856.
77. q/11 proteins in spontaneously hypertensive rats. Am J Physiol 1997; 272:F339-F346.
78. Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001; 345:1548-1557.
79. Bughi S, Horton R, Antonipillai I, Manoogian C, Ehrlich L, Nadler J. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects. J Clin Endocrinol Metab 1989; 69:1116-1121.
80. Chatziantoniou C, Ruan X, Arendshorst WJ. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am J Physiol 1993; 265:F845-F852.
81. Krushkal J, Xiong M, Ferrell R, Sing CF, Turner ST, Boerwinkle E. Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet 1998; 7:1379-1383.
82. Staessen JA, Kuznetsova T, Zhang H, Maillard M, Bochud M, Hasenkamp S, Westerkamp J, Richart T, Thijs L, Li X, Brand-Herrmann SM, Burnier M, Brand E. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension 2008; 51:1643-1650.
83. 1 receptor gene polymorphism is associated with essential hypertension. Hypertension 2000; 36:183-186.
84. Lu Y, Zhu H, Wang X, Snieder H, Huang Y, Harshfield GA, Treiber FA, Dong Y. Effects of dopamine receptor type 1 and Gs protein α subunit gene polymorphisms on blood pressure at rest and in response to stress. Am J Hypertens 2006; 19:832-836.
85. 1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 2008; 51: 367-375.
86. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18:655-673.
87. Prabha PS, Das UN, Koratkar R, Sagar PS, Ramesh G. Free radical generation, lipid peroxida-tion and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot Essent Fatty Acids 1990; 41:27-33.
88. Forde P, Scribner AW, Dial R, Loscalzo J, Trolliet MR: Prevention of hypertension and renal dysfunction in Dahl rats by alpha-tocopherol. J Cardiovasc Pharmacol 2003; 42:82-88.
89. Midaoui AE, Elimadi A, Wu L, Haddad PS, de Champlain J. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am J Hypertens 2003; 16:173-179.
90. Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med. 2008; 86:729-734.
91. 1-receptor-G-protein coupling and function in obese Zucker rats. Diabetes 2005; 54:2219-2226.
92. Marwaha A, Lokhandwala MF. Tempol reduces oxidative stress and restores renal dopamine D1-like receptor- G protein coupling and function in hyperglycemic rats. Am J Physiol Renal Physiol 2006; 291:F58-F66.
93. 1 receptor signaling in the renal proximal tubules of Sprague-Dawley rats. Free Radic Biol Med 2007; 42:756-764.
94. Asghar M, Banday AA, Fardoun RZ, Lokhandwala MF. Hydrogen peroxide causes uncoupling of dopamine D1-like receptors from G proteins via a mechanism involving protein kinase C and G-protein-coupled receptor kinase 2. Free Radic Biol Med 2006; 40:13-20.
95. 1 Dopamine receptor down-regulates NADPH oxidase activity via a protein kinase C and protein kinase A cross-talk in human kidney cells. FASEB J 2008; 22:969 (abstract).
96. Amenta F. Light microscope autoradiography of peripheral dopamine receptor subtypes. Clin Exp Hypertens 1997; 19:27-41.
97. 5 dopamine receptors in the nephron. Hypertension 2003; 41:604-610.
98. 1. Nature 1991; 350:614-619.
99. 5 dopamine receptors. Cardiovasc Hematol Agents Med Chem 2007; 5:241-248.
100. 5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 2006; 290:R96-R104.
101. Yao LP, Huque E, Baraniuk J, Carey RM, Felder RA, Jose PA. Dopamine receptor subtype expression (D1A AND D1B) in rat nephron segments. J Invest Med 1996; 44: 305A (abstract).
102. Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 2005; 90:449-455.
103. 1-like receptors. Circulation 2000; 101:2302-2308.
104. Allayee H, de Bruin TW, Michelle Dominguez K, Cheng LS, Ipp E, Cantor RM, Krass KL, Keulen ET, Aouizerat BE, Lusis AJ, Rotter JI. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 2001; 38:773-778.
105. 5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics 1999; 9:199-206.
106. 5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 2002; 22:10801-10810.
107. 1-like receptor-dependent protective effect. Free Radic Biol Med 2004; 36:1233-1234.
108. Sam EE, Verbeke N. Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in Parkinsonism. J Neural Transm 1995; 10:115-127.
109. 5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 2005; 288:H55-H61.
110. Huang P, Frohman MA. The potential for phospholipase D as a new therapeutic target. Expert Opin Ther Targets 2007; 11:707-716.
111. Min DS, Lee KH, Chang JS, Ahn BH, Rhie DJ, Yoon SH, Hahn SJ, Kim MS, Jo YH. Altered expression of phospholipase D1 in spontaneously hypertensive rats. Mol Cells 2001; 11:386-391.
112. 1 receptor and protein kinase C isoforms in spontaneously hypertensive rats. Hypertension 1998; 32:1049-1053.
113. 5 receptors. J Neurochem 2005; 95:1387-1400.
114. 1-like receptor inhibits reactive oxygen species production by interfering with the distribution and assembly of NAD(P)H oxidase components. Council for High Blood Pressure Research 2005; 151 (abstract).
115. Han W, Villar VAM, Li H, Jose PA, Yu P. Differential targeting of NADPH oxidase to lipid rafts of renal proximal tubule cells. FASEB J 2007; 21:A358 (abstract).
116. Lu Q, Asico LD, Jones JE, Yu P, Maines MD, Felder RA, Jose PA. D5 dopamine receptor regulation of ROS through heme-oxygenase. J Clin Hypertens 2007; 9 (suppl A): A116 (abstract).
117. 2 dopamine receptors produced by alternative RNA splicing. Nature 1989; 342:926-929.
118. 2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function. Neuropharmacology 2006; 50:595-605.
119. 2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci U S A 2003; 100: 4305-4309.
120. 2 subfamily of dopamine receptor genes in kidney. Am J Physiol 1994; 266:F646-F650.
121. 2 receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells. J Am Soc Nephrol 2001; 12:1844-1852.
122. 2 receptors in rat heart and coronary vessels. Clin Exp Pharmacol Physiol 2002; 29:412-418.
123. Zeng C, Armando I, Luo Y, Eisner GM, Felder RA, Jose PA. Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol 2008; 294:H551-H569.
124. 2 receptor modulates sodium handling via local production of dopamine in the kidney. J Cardiovasc Pharmacol 2003; 42:S75-S79.
125. 2 receptor. EMBO J 2007; 26: 2127-2036.
126. Li XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein DS, Rubinstein M, Eisner GM, Jose PA. Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension 2001; 38:303-308.
127. Ueda A, Ozono R, Oshima T, Yano A, Kambe M, Teranishi Y, Katsuki M, Chayama K. Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Am J Hypertens 2003; 16:853-858.
128. 2-like receptors causes recruitment of tyrosine-phosphorylated NKA alpha 1-subunits in kidney. Am J Physiol Renal Physiol 2002; 283:F1290-F1295.
129. + ATPase activity in murine LTK2 cells. Mol Pharmacol 1996; 49:373-378.
130. 2 dopamine receptor synergism. Nature 1990; 347:386-388.
131. Bertorello A, Aperia A. Inhibition of proximal tubule Na(+)-K(+)-ATPase activity requires simultaneous activation of DA1 and DA2 receptors. Am J Physiol 1990; 259:F924-F928.
132. 2 receptor synergism. Nature 1991; 353:164-167.
133. 2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Mol Pharmacol 1991; 39:364-369.
134. +-ATPase activity in the proximal tubule. Am J Physiol Renal Physiol 2007; 292:F1435-F1442.
135. Eklof AC. The natriuretic response to a dopamine DA1 agonist requires endogenous activation of dopamine DA2 receptors. Acta Physiol Scand 1997; 160:311-314.
136. 2-like receptors on renal function. Am J Physiol 1998; 275:R986-R994.
137. 3 receptor in the rat kidney. Eur J Pharmacol 1997; 338:89-95.
138. 3 receptor protein in the rat kidney. Hypertension 1998; 32:886-895.
139. 3 receptor activation modulates renal function in anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 1998; 358:690-693.
140. 3 dopamine receptor stimulation induces natriuresis by endothelin receptor interactions. Kidney Int 2008; 74(6):750-759.
141. 3 receptors and salt-dependent hypertension. J Am Soc Nephrol 2001; 12:2272-2279.
142. 3 dopamine receptor and essential hypertension. Curr Hypertens Rev 2006; 2:247-253.
143. 4 receptor isoform mRNA and protein are expressed in the rat cortical collecting duct. Am J Physiol 1998; 275:F742-F751.
144. 4 receptor expression in rat kidney: evidence for pre- and postjunctional localization. Histochem Cytochem 2002; 50:1091-1096.
145. Ricci A, Mignini F, Tomassoni D, Amenta F. Dopamine receptor subtypes in the human pulmonary arterial tree. Auton Autacoid Pharmacol 2006; 26:361-369.
146. Amenta F, Barili P, Bronzetti E, Felici L, Mignini F, Ricci A. Localization of dopamine receptor subtypes in systemic arteries. Clin Exp Hypertens 2000; 22:277-288.
147. 4 receptor in the heart. J Auton Pharmacol 1998; 18:115-121.
148. 2-like receptors in the guinea pig heart. Can J Physiol Pharmacol 2002; 80:578-587.
149. 4-like receptor. Am J Physiol 1996; 271:F391-F400.
150. Saito O, Ando Y, Kusano E, Asano Y. Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD. Am J Physiol Renal Physiol 2001; 281:F114-F122.
151. 2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf) 2001; 55:605-611.
152. 2 receptor gene TaqI polymorphism. Hypertension 2000; 36:177-182.
153. Kren V, Pravenec M, Lu S, Krenova D, Wang JM, Wang N, Merriouns T, Wong A, St Lezin E, Lau D, Szpirer C, Szpirer J, Kurtz TW. Genetic isolation of a region of chromosome 8 that exerts major effects on blood pressure and cardiac mass in the spontaneously hypertensive rat. J Clin Invest 1997; 99:577-581.
154. 3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells. J Med Genet 2004; 41:867-871.
155. 3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia. Mol Psychiatry 2000; 5:433-438.
156. 3 receptor gene polymorphisms, blood pressure and nephropathy in type 1 diabetic patients. Nephrol Dial Transplant 2004; 19:1432-1436.
157. 3 receptor gene produces renin-dependent hypertension. J Clin Invest 1998;
158. 3 receptor knockout mice. Hypertens Res 2007; 30:93-101.
159. Armando I, Wang X, Jones JE, Asico LD, Jose PA. Impaired response to chronic sodium loading in dopamine D3 receptor deficient mice. Am J Hypertens 2005; 18:126A (abstract).
160. 2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 2001; 281:R1071-R1078.
161. 3 receptors directly regulate NHE3 in renal proximal tubules. J Am Soc Nephrol 2007; 18: 597A (abstract).
162. Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, Paigen B. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics 2001; 71:70-77.
163. Sen S, Nesse R, Sheng L, Stoltenberg SF, Gleiberman L, Burmeister M, Weder AB. Association between a dopamine-4 receptor polymorphism and blood pressure. Am J Hypertens 2005; 18:1206-1210.
164. 4 dopamine receptor-deficient mice. Hypertension 2006; 47:288-295.
165. 3 dopamine receptor activates phospholipase D through a pertussis toxin-insensitive pathway. Neurosci Lett 2004; 371:34-39.
166. 3 dopamine receptor agonists. Parkinsonism Relat Disord 2001; 7:213-223.
167. 4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein. J Cereb Blood Flow Metab 2005; 25: 794-806.
168. 4 receptors inhibits oxidative stress-induced nerve cell death. J Neurosci 2001; 21:6069-6076.
169. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999; 27:612-616.
170. Bianchi P, Seguelas MH, Parini A, Cambon C. Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. J Am Soc Nephrol 2003; 14:855-862.
171. Cantuti-Castelvetri I, Joseph JA. Differential effect of dopamine catabolism and uptake inhibition on dopamine-induced calcium dysregulation and viability loss. Free Radic Biol Med 1999; 27:1393-1404.
172. Wersinger C, Prou D, Vernier P, Sidhu A. Modulation of dopamine transporter function by α-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J 2003; 17:2151-2153.
173. 1 receptor activation. J Neurochem 2001; 79:63-70.
174. Gassen M, Glinka Y, Pinchasi B, Youdim MB. Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction. Eur J Pharmacol 1996; 308:219-225.
175. 1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 2008; 51: 367-375.
176. Wang ZQ, Siragy HM, Felder RA, Carey RM. Intrarenal dopamine production and distribution in the rat. Physiological control of sodium excretion. Hypertension 1997; 29:228-234.
177. Wang Z, Armando I, Asico LD, Escano C, Wang X, Lu Q, Felder RA, Schnackenberg CG, Sibley DR, Eisner GM, Jose PA. The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production. Am J Physiol Heart Circ Physiol 2007; 292:H2083-H2092.
178. Simão S, Fraga S, Jose PA, Soares-da-Silva P. Oxidative stress plays a permissive role in alpha2-adrenoceptor-mediated events in immortalized SHR proximal tubular epithelial cells. Mol Cell Biochem 2008; 315(1-2):31-39.
179. Touyz RM, Schiffrin EL. Reactive oxygen species and hypertension: a complex association. Antioxid Redox Signal 2008; 10:1041-1044.
180. Pinto V, Pinho MJ, Hopfer U, Jose PA, Soares-da-Silva P. Oxidative stress and the genomic regulation of aldosterone-stimulated NHE1 activity in SHR renal proximal tubular cells. Mol Cell Biochem 2008; 310:191-201.
181. Zeng C, Villar VA, Eisner GM, Williams SM, Felder RA, Jose PA. G protein-coupled receptor kinase 4. Role in blood pressure regulation. Hypertension 2008; 51:1449-1455.